Senior insider sale
ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$433.9K
10.24K shares
What this filing means
ORBIMED CAPITAL LLC plans to sell 10.24K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $433.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/16/2026ACC: 0000947871-26-000629
Director10% Owner
Since Jul 2021
10.24K
Shares to sell
$433.9K
Approx. market value
10.24K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Merger
N/A
2/23/2023
10.24KTotal acquired10.24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2023 | Merger N/A | 10.24K | — |
| Total | 10.24K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
10.24K
Market value
$433.9K
6/15/2026
Total
Units
10.24K
Value
$433.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2026 | 10.24K | $433.9K | Nasdaq Stock Market | Planned |
| Total | 10.24K | $433.9K | ||